A. Andrieux, P. A. Salin, and M. Vernet, The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders, Genes & Development, vol.16, issue.18, pp.2350-2364, 2002.
DOI : 10.1101/gad.223302

P. Batel, Addiction and schizophrenia, European Psychiatry, vol.15, issue.2, pp.115-122, 2000.
DOI : 10.1016/S0924-9338(00)00203-0

G. Benitez-king, G. Ramirez-rodriguez, L. Ortiz, and I. Meza, The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia, Current Drug Target -CNS & Neurological Disorders, vol.3, issue.6, pp.515-533, 2004.
DOI : 10.2174/1568007043336761

C. Bosc, J. D. Cronk, F. Pirollet, D. M. Watterson, J. Haiech et al., Cloning, expression, and properties of the microtubule-stabilizing protein STOP., Proc. Natl. Acad. Sci. U S A 93, pp.2125-2130, 1996.
DOI : 10.1073/pnas.93.5.2125

C. Bouvrais-veret, S. Weiss, A. Andrieux, A. Schweitzer, J. M. Mcintosch et al., Sustained increase of alpha7 nicotinic receptors and choline-induced improvement of learning deficit in STOP knock-out mice, Neuropharmacology, vol.52, issue.8, pp.1691-1700, 2007.
DOI : 10.1016/j.neuropharm.2007.03.015

URL : https://hal.archives-ouvertes.fr/inserm-00379958

E. Brenner, U. Sonnewald, A. Schweitzer, A. Andrieux, and A. Nehlig, Hypoglutamatergic activity in the STOP knockout mouse: A potential model for chronic untreated schizophrenia, Journal of Neuroscience Research, vol.18, issue.15, 2007.
DOI : 10.1002/jnr.21200

URL : https://hal.archives-ouvertes.fr/inserm-00379976

P. Brun, M. Begou, A. Andrieux, L. Mouly-badina, M. Clerget et al., Dopaminergic transmission in STOP null mice, Journal of Neurochemistry, vol.65, issue.1, pp.63-73, 2005.
DOI : 10.1016/0165-0173(90)90015-G

URL : https://hal.archives-ouvertes.fr/inserm-00380189

A. Couegnas, A. Schweitzer, A. Andrieux, M. S. Ghandour, and N. Boehm, Expression pattern of stop lacZ reporter gene in adult and developing mouse brain, Journal of Neuroscience Research, vol.3, issue.7, pp.1515-1527, 2007.
DOI : 10.1002/jnr.21278

URL : https://hal.archives-ouvertes.fr/inserm-00379995

S. L. Eastwood, L. Lyon, L. George, A. Andrieux, D. Job et al., Altered expression of synaptic protein mRNAs in STOP (MAP-6) mutant mice, J. Psychopharmacol, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00380032

P. O. Fernagut, S. Chalon, E. Diguet, D. Guilloteau, F. Tison et al., Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice, Neuroscience, vol.116, issue.4, pp.1123-1130, 2003.
DOI : 10.1016/S0306-4522(02)00778-9

R. L. Fradley, G. F. O-'meara, R. J. Newman, A. Andrieux, D. Job et al., STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating, Behavioural Brain Research, vol.163, issue.2, pp.257-264, 2005.
DOI : 10.1016/j.bbr.2005.05.012

URL : https://hal.archives-ouvertes.fr/inserm-00380197

W. G. Frankle, J. Lerma, and M. Laruelle, The Synaptic Hypothesis of Schizophrenia, Neuron, vol.39, issue.2, pp.205-216, 2003.
DOI : 10.1016/S0896-6273(03)00423-9

R. R. Gainetdinov, A. R. Mohn, and M. G. Caron, Genetic animal models: focus on schizophrenia, Trends in Neurosciences, vol.24, issue.9, pp.527-533, 2001.
DOI : 10.1016/S0166-2236(00)01886-5

B. Giros and M. G. Caron, Molecular characterization of the dopamine transporter, Trends in Pharmacological Sciences, vol.14, issue.2, pp.43-49, 1993.
DOI : 10.1016/0165-6147(93)90029-J

B. Giros, S. Mestikawy, N. Godinot, K. Zheng, H. Han et al., Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter, Mol. Pharmacol, vol.42, pp.383-390, 1992.

B. Giros, M. Jaber, S. R. Jones, R. M. Wightman, and M. G. Caron, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, vol.379, issue.6566, pp.606-612, 1996.
DOI : 10.1038/379606a0

A. H. Glassman, Cigarette smoking: implications for psychiatric illness, Am J Psychiatry, vol.150, pp.546-553, 1993.

L. Guillaud, C. Bosc, A. Fourest-lieuvin, E. Denarier, F. Pirollet et al., STOP Proteins are Responsible for the High Degree of Microtubule Stabilization Observed in Neuronal Cells, The Journal of Cell Biology, vol.15, issue.1, pp.167-179, 1998.
DOI : 10.1083/jcb.133.1.151

E. V. Gurevich, Y. Bordelon, R. M. Shapiro, S. E. Arnold, R. E. Gur et al., Mesolimbic Dopamine D3 Receptors and Use of Antipsychotics in Patients With Schizophrenia, Archives of General Psychiatry, vol.54, issue.3, pp.225-232, 1997.
DOI : 10.1001/archpsyc.1997.01830150047009

K. Ishizuka, M. Paek, A. Kamiya, and A. Sawa, A Review of Disrupted-in-Schizophrenia-1 (disc1): Neurodevelopment, Cognition, and Mental Conditions, Biological Psychiatry, vol.59, issue.12, pp.1189-1197, 2006.
DOI : 10.1016/j.biopsych.2006.03.065

S. Jamain, H. Quach, C. Betancur, M. Rastam, C. Colineaux et al., Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism, Nature Genetics, vol.34, issue.1, pp.27-29, 2003.
DOI : 10.1038/ng1136

URL : https://hal.archives-ouvertes.fr/inserm-00124744

S. R. Jones, R. R. Gainetdinov, M. Jaber, B. Giros, R. M. Wightman et al., Profound neuronal plasticity in response to inactivation of the dopamine transporter, Proc. Natl. Acad. Sci. U S A 95, pp.4029-4034, 1998.
DOI : 10.1073/pnas.95.7.4029

D. Levesque, M. P. Martres, J. Diaz, N. Griffon, C. H. Lammers et al., A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons., Proc. Natl. Acad. Sci. U S A 92, pp.1719-1723, 1995.
DOI : 10.1073/pnas.92.5.1719

C. M. Lewis, D. F. Levinson, and L. H. Wise, Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia, The American Journal of Human Genetics, vol.73, issue.1, pp.34-48, 2003.
DOI : 10.1086/376549

O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem, vol.193, pp.265-275, 1951.

M. P. Martres, M. L. Bouthenet, N. Salés, P. Sokoloff, and J. C. Schwartz, Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand, Science, vol.228, issue.4700, pp.752-755, 1985.
DOI : 10.1126/science.3838821

M. P. Martres, B. Demeneix, N. Hanoun, M. Hamon, and B. Giros, Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain, European Journal of Neuroscience, vol.3, issue.12, pp.3607-3616, 1998.
DOI : 10.1046/j.1460-9568.1998.00366.x

K. Mirnics, F. A. Middleton, D. A. Lewis, and P. Levitt, Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse, Trends in Neurosciences, vol.24, issue.8, pp.479-486, 2001.
DOI : 10.1016/S0166-2236(00)01862-2

J. A. Morris, G. Kandpal, L. Ma, and C. P. Austin, DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation, Human Molecular Genetics, vol.12, issue.13, pp.1591-1608, 2003.
DOI : 10.1093/hmg/ddg162

M. J. Owen, N. Craddock, O. Donovan, and M. C. , Schizophrenia: genes at last?, Trends in Genetics, vol.21, issue.9, pp.518-525, 2005.
DOI : 10.1016/j.tig.2005.06.011

M. J. Owen, M. C. O-'donovan, and P. J. Harrison, Schizophrenia: a genetic disorder of the synapse?, BMJ, vol.330, issue.7484, pp.158-159, 2005.
DOI : 10.1136/bmj.330.7484.158

P. Seeman and S. Kapur, Schizophrenia: More dopamine, more D2 receptors, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.7673-7675, 2000.
DOI : 10.1073/pnas.97.14.7673

H. Shimizu, Y. Iwayama, and K. Yamada, Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia, Schizophrenia Research, vol.84, issue.2-3, pp.244-252, 2006.
DOI : 10.1016/j.schres.2006.03.017

G. D. Stanwood, R. P. Artymyshyn, M. P. Kung, H. F. Kung, I. Lucki et al., Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [ 125 I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals, J. Pharmacol. Exp. Ther, vol.295, pp.1223-1231, 2000.

D. Van-rossum and U. K. Hanisch, Cytoskeletal dynamics in dendritic spines: direct modulation by glutamate receptors? Trends Neurosci, pp.290-295, 1999.

S. Weiss, E. T. Tzavara, R. J. Davis, G. G. Nomikos, J. M. Mcintosh et al., Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice, Neuropharmacology, vol.52, issue.7, pp.1496-1508, 2007.
DOI : 10.1016/j.neuropharm.2007.02.002

B. Winklbaur, N. Ebner, G. Sachs, K. Thau, and G. Fischer, Substance abuse in patients with schizophrenia, Dialogues Clin Neurosci, vol.8, pp.37-43, 2006.

M. Zervas, T. Opitz, W. Edelmann, B. Wainer, R. Kucherlapati et al., Impaired hippocampal long-term potentiation in microtubule-associated protein 1B-deficient mice, Journal of Neuroscience Research, vol.34, issue.1, pp.83-92, 2005.
DOI : 10.1002/jnr.20624